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tation of emergency neurology 
and neurosurgical practice of 
new drugs capable of influencing 
secondary damage of neurons in 
patients with traumatic brain in-
jury (TBI), allowed to significantly 
influence the recovery of such pa-
tients, reduce the duration of stay 
in therapy department; improve 
cognitive function rehabilitation 
and recovery. The high expecta-
tions of modern medicine for neu-
roprotective therapy have stimu-
lated scientists all over the world 
to actively search for new effective 
drugs of influencing the patho-
physiological cascades of neuronal 
damage development [1, 2].
One of the trigger mecha-
nisms for brain damage is the 
disruption of energy supply. The 
mismatch of energy production 
in the system of mitochondri-
al oxidative phosphorylation 
of the energy consumption of 
brain cells leads to disruption 
of numerous energy dependent 
processes: membrane transport, 
synthesis of structural mol-
ecules, bioregulators and neu-
rotransmitters, etc. [3]. It is quite 
clear that the effectiveness of 
neuroprotective agents is large-
ly determined by their ability 
to normalize the metabolism of 
adenylated nucleotides and the 
associated biochemical processes 
in the brain [4].
Today, the main component 
of intensive care for TBI is ther-
apy, which includes a number of 
interventions aimed at preventing 
the development and correcting 
the manifestations of homeostasis 
disorders that go along with trau-
matic brain damage. According 
to modern ideas, cerebroprotec-
tors can perform adequate pro-
tection of the brain against the 
background of traumatic damage 
[5, 6]. One of the complications 
accompanying TBI is acute cere-
bral ischemia [6]. The choice of 
medicines (drugs) for brain inju-
ries is one of the most complex 
problems in the treatment of such 
patients [7].
Considering this, it is of great interest to study the effect 
of various cerebroprotectors on the state of energy metabolism 
in TBI.
The aim of the study was to evaluate the magnitude of the 
cerebroprotective effect of amantadine sulfate on the possibility 
of pharmacological correction of 
carbohydrate metabolism disor-
ders in the rat brain against ex-
perimental TBI. 
2. Materials and methods
The studies were conducted 
at the Vinnytsia National Med-
ical University for the period 
2016–2019.
The experiments were per-
formed on white male rats weigh-
ing 160–190 g, who were in the 
vivarium of the VNMU named 
after M.I. Pirogov on a standard 
water and food ration (chilled 
boiled water, fodder grain, bread, 
granulated feed, temperature 20–
24 °C, humidity 50–55 %) in nat-
ural light 12 hours a day and free 
access to water and feed, in com-
pliance with the ethical standards 
of experimental research in accor-
dance with the “General principles 
of work on animals”, approved by 
the First National Congress on 
Bioethics (Kyiv, Ukraine, 2001) 
and the Law of Ukraine “On the 
Protection of Animals against 
Cruelty” of 26.02.2006. TBI ex-
perimental model was caused by 
action of flow of carbon dioxide 
under pressure created with the 
use of a gas cylinder of pneumat-
ic gun brand “Baikal MR-654K” 
(RF, Izhevsk, No. ROSS certificate 
RU MZH03.V02518) and carbon 
dioxide cylinders (mass of lique-
fied CO2 (12 gm), under pressure 
of CO2 – 12 g) USA, lot number 
456739). Rats under conditions of 
propofol anesthesia (60 mg/kg), 
after catheterization of the femo-
ral vein and the possibility of in-
fusion through the pump system, 
performed right-sided bone-plas-
tic trepanation of the skull of the 
projection of the middle cerebral 
artery, with a hole diameter of 
5 mm2. After fixation of the rat in 
a position on the abdomen upside 
down, a shot was taken from a 
fixed distance (close-up shot), the 
bone fragment on the periosteum 
together with aponeurosis was re-
turned to the site and the wound 
was sutured in layers. Thus, the 
TBI was heavily modelled.
The therapeutic effect of amantadine sulfate (PC-Merz, 
Merz Pharmaceuticals, Switzerland), 1 vial of 500 ml at a 
concentration of 200 mg/500 ml on model TBI was evaluated 
by the administration of a dose of 5 mg/kg intravenously. The 
treatment was performed by slow intravenous (I/V) infusion 
with infusion pump at intervals of 2 g/d (every 12 h) for 
EFFECTIVENESS OF CORRECTION OF  
DISCUSSION OF CARBOHYDRATE  








Department of Anesthesiology,  
Intensive Care and Emergency Medicine1
1Pirogov National Memorial Medical University
56 Pirogova str., Vinnytsya, Ukraine, 21018
Abstract: The development and introduction into practice of 
emergency neurology of new drugs capable of influencing 
secondary neuronal damage in patients with traumatic brain 
injury (TBI) has made a significant impact on the recovery of 
such patients. 
Aim of the work was to evaluate the magnitude of cerebro-
protective action of amantadine sulfate in terms of impaired 
carbohydrate metabolism of the brain against the back-
ground of experimental TBI. 
Materials and methods. The experimental model of severe 
TBI was caused by the action of a carbon dioxide flow under 
pressure, which was created using a gas balloon of pneumat-
ic gun. The therapeutic effect of amantadine sulfate on TBI 
model was evaluated with a 5 mg/kg dose. The pseudo-oper-
ated animals and control group received 0.9 % NaCl solution 
at a dose of 2 ml/kg with IV administration. 
Results. The obtained results confirm the formation of a hy-
po-energetic state in the brain cells of rats on the background 
of TBI, which is probably a consequence of the suppression of 
the processes of oxidative phosphorylation and its conjuga-
tion with tissue respiration. TBI is accompanied by activation 
of anaerobic glycolysis and inhibition of aerobic glucose oxi-
dation, proving that there is an imbalance between the levels 
of lactate and pyruvate intermediates. 8-day infusion of rats 
with traumatic brain injury of amantadine sulfate, inhibited 
anaerobic glycolysis hyperactivation, stimulated tissue respi-
ration processes, reduced signs of lactic acidosis and develop-
ment of secondary alteration of brain cells by non-oxidized 
products.
Conclusions. In the course of the experiment, it was found 
that the treatment of rats, with TBI model, with 0.9 % NaCl 
solution did not significantly contribute to the restoration of 
impaired energy metabolism (p<0.05) and did not reduce 
the manifestation of metabolic acidosis in the damaged brain 
(p<0.05). The use of amantadine sulphate in TBI rats signif-
icantly corrects carbohydrate metabolism disorders than 
0.9 % NaCl solution and contributes to the reduction of met-
abolic acidosis in the damaged brain (p<0.05).
Keywords: traumatic brain injury, amantadine sulfate, rats.
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8 days. Treatment was started 1 hour after the simulation of 
the pathological condition. The pseudo-operated animals 
were subjected to all interventions (anaesthesia, skin inci-
sion, bone-plastic skull trepanation) with the exception of 
manipulations that could directly lead to traumatic brain 
injury, which nullified the effects of trauma. They were also 
administered an equivalent amount of 0.9 % NaCl solution 
up to a dose of amantadine sulfate. As a drug for the control 
group used 0.9 % solution of HCl at a dose of 2 ml/kg in/in 
the same mode.
For biochemical studies, after euthanasia of 
animals, the brain of rats was isolated, perfused 
with a cold 1.15 % potassium chloride solution and 
homogenized at 3000 rpm (Tef lon glass) in an en-
vironment of 1.15 % potassium chloride (1:3 ratio). 
The homogenates were centrifuged for 30 min at 
600 g, aliquots of post-nucleus supernatant were 
collected into Erpendorf microtubes and stored at 
20 °C until testing.
The content of adenyl nucleotides was deter-
mined in protein-free trichloroacetic extract of brain 
tissues 1:10 (10 % trichloroacetic acid solution) by 
chromatographic method. Content of pyruvate and 
lactate-calorimetric method [9]. The energy charge 











The obtained results were processed by the method 
of variational statistics using Student’s t-test, changes 
of indicators were considered reliable at p≤0.05. 
3. Results
Disruption of energy metabolism in traumatically damaged 
neurons is one of the main pathogenetic mechanisms for the 
development of neurodegradative changes in TBI. Therefore, it 
was advisable to evaluate the state of energy metabolism in the 
tissues of the brain of rats by TBI and based on 8-day therapy 
course with amantadine sulfate.
The results of the study showed that the animals of the con-
trol pathology group observed disorders of energy metabolism 
in brain tissues and develops a hypo-energetic state (Table 1). 
In pseudo-operated rats in brain tissues, the ATP level was in 
the range of 1.50–4.73 µmol/g of dry tissue, the ADP content 
was 0.904–1.02 µmol/g of dry tissue, the concentration of AMP 
was 0.608–0.743 µmol/g of dry tissue, and the energy charge 
(P5-P95). At the same time, in untreated TBI animals, the ATP 
level in the brain was lower by 47.1 % (p<0.05), compared to the 
pseudo-operated animals, and ranged from 1.44 to 1.88 μmol/g 
of dry tissue (P5-P95). Under these conditions, the content of 
ADP and AMP exceeded the values of pseudo-operated animals 
by 130 and 58.9 % (p<0.05), and varied respectively within 
1.94–2.43 µmol/g of dry tissue and 0.95–1.14 μmol/g of dry 
tissue (P5-P95). In addition, the CCI changed the ratio between 
adenyl nucleotides, as evidenced by a likely decrease in energy 
charge of 73.0 % (p<0.05). Thus, in pseudo-operated animals the 
energy charge varied within 0.753–0.786, and in animals of the 
control pathology group was in the range 0.547–0.579 (P5-P95).
The results confirm the formation of a hypo-energetic state 
in the brain cells of rats on the background of TBI, which is 
probably a consequence of the suppression of the processes of 
oxidative phosphorylation and its conjugation with tissue res-
piration.
It has been established that the course administration of 
amantadine sulfate somewhat prevented perturbations in the 
metabolism of adenyl nucleotides. In the group of animals treat-
ed with amantadine, the ATP content and energy charge were 
52.4 and 23.4 % (p<0.05) higher, compared to the pseudoperated 
animals, and varied in the range 2.13–2.87 μmol/g dry cloth 
(P5-P95) and 0.674–0.709, respectively. Under these conditions, 
the concentrations of ADP and AMP in the brain were lower by 
36.6 and 30.5 % (p<0.05), compared with pseudoperated ani-
mals, and varied between 1.28–1.51 and 0.686–0.7772 µmol/g of 
dry tissue (P5-P95), respectively.
Numerous experimental studies have shown that the for-
mation of ATP deficiency and excess of di- and three phosphate 
nucleosides in brain structures by TBI causes activation of 
the anaerobic glycolysis regulatory enzymes by the allosteric 
mechanism. Hyperactivation of glycolysis was accompanied by 
increased production of lactic acid, the development of metabol-
ic acidosis, which deepens the alteration of brain cells by TBI.
The results of our studies confirm the fact that TBI was ac-
companied by activation of anaerobic glycolysis and inhibition 
of aerobic glucose oxidation, which is evidence of an imbalance 
between the levels of lactate and pyruvate intermediates. In 
pseudo-operated animals, the level of lactate varies within 
1.68–1.98 μmol/g of dry tissue (P5-P95), pyruvate – in the range 
of 0.255–0.417 μmol/g of dry tissue (P5-P95), and the ratio of 
lactate/pyruvate was in the range of 3.94–6.96. Instead, a sta-
tistically significant increase in lactate levels of 3.58-fold (in the 
range of 6.55–7.47 µmol/g of dry tissue) was observed with TBI, 
a decrease in pyruvate content of 56.2 % (ranges from 0.122–
0.178 µmol/g of dry tissue) and an increase of lactate/pyruvate 
ratio of 8.64 times compared to pseudo-operated animals.
The use of amantadine sulfate decreased the activity of 
anaerobic glycolysis, promoted the activation of aerobic glucose 
oxidation and reduced the signs of lactic acidosis in brain cells 
by TBI (Table 2). The use of amantadine sulfate effectively in-
fluenced the processes of aerobic metabolism of carbohydrates. 
In the group of animals administered 8-day infusion of aman-
tadine, a significant decrease in lactic acid content by 2.1 times 
(its level ranged from 2.57–4.22 µmol/g of dry tissue), a pyruvate 
increase of 109 % (was in the range of 0.274–0.357 μmol/g dry 
tissue) and a decrease in the ratio of lactate / pyruvate 4.3 times, 
compared with the animals in the control group of pathology.
Table 1
Effect of a 8-day course infusion of amantadine sulfate on the content of 















animals + 0.9 % NaCl 
solution
3.13±0.49 0.957±0.018 0.667±0.022 0.767±0.006
TBI + 0.9 % NaCl 
solution (control 
pathology)
 1.66± 0.07º 2.20±0.07º 1.06± 0.03º 0.560±0.006º
TBI + amantadine 
sulfate,  
5 mg / kg
2.52±0.11º* 1.40±0.04º* 0.737±0.014º* 0.691±0.006º*
Note: TBI – traumatic brain injury; º – p<0.05 relative to pseudo-operated animals; 
* – p<0.05 relative to the control pathology group
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Table 2
Effect of 8-day infusion course of amantadine sulfate on  
the content of glucose metabolites in the brain of rats with 












animals + 0.9 % NaCl 
solution
1.82±0.05 0.347±0.025 5.45±0.45




TBI + amantadine 
sulfate, 5 mg / kg 3.42±0.24
о* 0.317±0.012о* 10.9±0.84о*
Note: TBI – traumatic brain injury; º – p<0.05 relative to pseudo-operat-
ed animals; * – p<0.05 relative to the control pathology group
4. Discussion and conclusions
In 2014, B. Elkon, J. R. Cambrin, E. Hirshberg, S. L. Bratton 
published the results of his own study examining the effect of 
blood glucose levels on the effects of TBI in children [10]. High 
blood glucose was associated with a 3.5-fold increase in poor 
prognosis compared to normal glycemic levels, adjusted for 
injury severity and cardiovascular instability [10].
The data obtained in our study indicate that 8-day infusion 
of rats with brain injury of amantadine sulfate, inhibited an-
aerobic glycolysis hyperactivation, stimulated tissue respiration 
processes, and reduced signs of lactic acidosis and development 
of secondary motility. Therefore, among the molecular mech-
anisms of cerebroprotective activity of amantadine sulfate 
should be highlighted its ability to reduce energy deficiency and 
improve aerobic glucose metabolism in rat brain cells against a 
background of traumatic brain injury.
Of considerable interest to the scientific community as 
well as to practical medicine are the results of the analysis of 
104 studies on the effects of hyperglycemia on the prognosis of 
adult patients with TBI, conducted by J. Peffer, C. McLaughlin 
[11]. Among the publications included in this study, the over-
whelming majority determined the negative impact of elevated 
glucose levels on the prognosis of patients with brain injury.
Compared with pseudo-operated animals, treatment of rats 
with a model TBI of 0.9 % NaCl solution did not significantly re-
store impaired energy metabolism (p<0.05) and did not reduce the 
manifestation of metabolic acidosis in the injured brain (p<0.05).
The use of amantadine sulphate in TBI rats significantly 
corrects carbohydrate metabolism disorders than 0.9 % NaCl 
solution and contributes to the reduction of metabolic acidosis 
in the damaged brain (p<0.05).
The therapeutic effect, which was obtained in the exper-
iment from therapy with amantadine sulfate, is the basis for 
studying the protective effect of other cerebroprotectors in 
treatment of TBI.
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